Over the last century, the primary burden of disease in children and young people has
shifted from infectious diseases towards chronic conditions. 1 Improvements in neonatal and …

Background Evidence on adverse effects of maternal macrolide use during pregnancy is
inconsistent. We conducted a systematic review and meta-analysis to investigate the …

Following the FDA black box warning in 2004, substantial reductions in antidepressant (ATD)
use were observed within 2 years in children and adolescents in several countries. …

Over the last two decades, the use of ADHD medication in US youth has markedly increased.
However, less is known about ADHD medication use among European children and …

Background Child mortality is almost twice as high in England compared with Sweden. We
aimed to establish the extent to which adverse birth characteristics and socioeconomic …

… Linda Wijlaars , Linda Wijlaars … Annie Herbert, Linda Wijlaars, Ania Zylbersztejn, David
Cromwell, Pia Hardelid, Data Resource Profile: Hospital Episode Statistics Admitted Patient Care (…

Background In 2003, the Committee on Safety of Medicines (CSM) advised against treatment
with selective serotonin reuptake inhibitors (SSRIs) other than fluoxetine in children, due to …

Objective: SES differences in infant weight gain in the first 3 months of life were examined,
and contributions of parental body mass index, maternal smoking and feeding method to this …

Over the last decades, an increase in antipsychotic (AP) prescribing and a shift from first-generation
antipsychotics (FGA) to second-generation antipsychotics (SGA) among youth have …

Introduction The coronavirus (COVID-19) pandemic has caused significant global mortality
and impacted lives around the world. Virus Watch aims to provide evidence on which public …